Skip to Content

Fenofibrate Pregnancy and Breastfeeding Warnings

Fenofibrate is also known as: Antara, Fenoglide, Lipidil EZ, Lipidil Micro, Lipidil Supra, Lipofen, Lofibra, TriCor, Triglide

Fenofibrate Pregnancy Warnings

This drug should be used during pregnancy only if the benefit outweighs the risk to the fetus; according to some experts, use is not recommended. AU TGA pregnancy category: B3 US FDA pregnancy category: C

Animal studies have revealed evidence of embryofetal toxicity and fetal abnormalities at higher doses that also produced maternal toxicity. There are no controlled data in human pregnancy. AU TGA pregnancy category B3: Drugs which have been taken by only a limited number of pregnant women and women of childbearing age, without an increase in the frequency of malformation or other direct or indirect harmful effects on the human fetus having been observed. Studies in animals have shown evidence of an increased occurrence of fetal damage, the significance of which is considered uncertain in humans. US FDA pregnancy category C: Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.

See references

Fenofibrate Breastfeeding Warnings

Animal studies in rats during lactation revealed evidence of decreased survival and weight gain in offspring.

Use should be avoided. Excreted into human milk: Unknown Excreted into animal milk: Data not available Comments: This drug should not be used during breastfeeding due to the potential for serious adverse events in nursing infants and the concern over disruption of infant lipid metabolism.

See references

References for pregnancy information

  1. "Product Information. Triglide (fenofibrate)." Sciele Pharma Inc, Atlanta, GA.
  2. Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0
  3. "Product Information. Tricor (fenofibrate)." Abbott Pharmaceutical, Abbott Park, IL.
  4. Cerner Multum, Inc. "Australian Product Information." O 0
  5. "Product Information. Fenoglide (fenofibrate)." Santarus Inc, San Diego, CA.
  6. "Product Information. Lofibra (fenofibrate)." Teva Pharmaceuticals (formerly Gate Pharmaceuticals), Sellersville, PA.
  7. "Product Information. Lipofen (fenofibrate)." Kowa Pharmaceuticals America (formerly ProEthic), Montgomery, AL.
  8. "Product Information. Fenofibrate (fenofibrate)." Mylan Pharmaceuticals Inc, Morgantown, WV.
  9. "Product Information. Antara (fenofibrate)." Lupin Pharmaceuticals Inc, Baltimore, MD.

References for breastfeeding information

  1. "Product Information. Fenoglide (fenofibrate)." Santarus Inc, San Diego, CA.
  2. "Product Information. Lofibra (fenofibrate)." Teva Pharmaceuticals (formerly Gate Pharmaceuticals), Sellersville, PA.
  3. "Product Information. Lipofen (fenofibrate)." Kowa Pharmaceuticals America (formerly ProEthic), Montgomery, AL.
  4. "Product Information. Fenofibrate (fenofibrate)." Mylan Pharmaceuticals Inc, Morgantown, WV.
  5. "Product Information. Tricor (fenofibrate)." Abbott Pharmaceutical, Abbott Park, IL.
  6. "Product Information. Antara (fenofibrate)." Lupin Pharmaceuticals Inc, Baltimore, MD.
  7. "Product Information. Triglide (fenofibrate)." Sciele Pharma Inc, Atlanta, GA.
  8. Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0
  9. Cerner Multum, Inc. "Australian Product Information." O 0

See Also...

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and Drugs.com is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.

Hide